Commentary: Induction immunotherapy for esophageal cancer: A safe start.
Publication
, Journal Article
Onaitis, M
Published in: J Thorac Cardiovasc Surg
March 2021
Duke Scholars
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
March 2021
Volume
161
Issue
3
Start / End Page
844
Location
United States
Related Subject Headings
- Respiratory System
- Immunotherapy
- Humans
- Feasibility Studies
- Esophagectomy
- Esophageal Neoplasms
- Chemoradiotherapy
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Onaitis, M. (2021). Commentary: Induction immunotherapy for esophageal cancer: A safe start. J Thorac Cardiovasc Surg, 161(3), 844. https://doi.org/10.1016/j.jtcvs.2020.12.027
Onaitis, Mark. “Commentary: Induction immunotherapy for esophageal cancer: A safe start.” J Thorac Cardiovasc Surg 161, no. 3 (March 2021): 844. https://doi.org/10.1016/j.jtcvs.2020.12.027.
Onaitis M. Commentary: Induction immunotherapy for esophageal cancer: A safe start. J Thorac Cardiovasc Surg. 2021 Mar;161(3):844.
Onaitis, Mark. “Commentary: Induction immunotherapy for esophageal cancer: A safe start.” J Thorac Cardiovasc Surg, vol. 161, no. 3, Mar. 2021, p. 844. Pubmed, doi:10.1016/j.jtcvs.2020.12.027.
Onaitis M. Commentary: Induction immunotherapy for esophageal cancer: A safe start. J Thorac Cardiovasc Surg. 2021 Mar;161(3):844.
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
March 2021
Volume
161
Issue
3
Start / End Page
844
Location
United States
Related Subject Headings
- Respiratory System
- Immunotherapy
- Humans
- Feasibility Studies
- Esophagectomy
- Esophageal Neoplasms
- Chemoradiotherapy
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences